Gilead Sciences Inc (NASDAQ:GILD, ETR:GIS) dropped up to 4% on Tuesday following an announcement that the US Food and Drug Administration (FDA) has placed clinical holds on studies involving two of the company's investigational HIV drugs. The FDA's clinical hold affects trials of GS-1720, an integrase strand transfer inhibitor, and GS-4182, a capsid inhibitor.

Broadcom Inc.'s latest quarter solidifies its premium status at the core of AI infrastructure growth, balancing rapid semiconductor expansion with VMware's stable software revenue, validating exceptional execution. CEO Hock Tan's disciplined capital management and prudent VMware integration underpin sustainable long-term margins, reinforcing investor confidence despite the richly valued current share price. Although near-term valuation is steep, AVGO stock remains a compelling strategic investment to capture lasting AI-driven secular growth, blending semiconductor innovation with predictable software cash flows.

"Sightwalks," the innovative tactile signage system created by Grey Peru, is transforming sidewalks for UNACEM/Sol Cemento NEW YORK , June 10, 2025 /PRNewswire/ -- Grey, a leading global ad agency, is proud to announce that it has been named an honoree of Fast Company's 2025 World Changing Ideas Awards, alongside its client UNACEM. This annual recognition honors transformative efforts that tackle the world's most pressing issues, from fresh sustainability initiatives and cutting-edge AI developments to ambitious pursuits of social equity that are helping mold the world.

PEG is poised to benefit from clean energy measures. The company is also investing in transmission and distribution infrastructure to meet customers' demand.

HON's acquisition of Sundyne will enable it to strengthen its product offerings and boost its Energy and Sustainability Solutions business.

LYFT surges 36.7% in 3 months, with strong bookings, upbeat guidance, and a $750 million buyback fueling momentum.

Jim Cramer breaks down why he's keeping an eye on shares of Cardinal Health.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DoubleVerify To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in DoubleVerify between November 10, 2023 and February 27, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 10, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DoubleVerify Holdings, Inc. ("DoubleVerify" or the …

Synchrony Financial (NYSE:SYF ) Morgan Stanley US Financials, Payments & CRE Conference 2025 June 10, 2025 8:15 AM ET Company Participants Brian J. Wenzel - Executive VP & CFO Conference Call Participants Jeffrey David Adelson - Morgan Stanley, Research Division Jeffrey David Adelson All right, everybody.

The semiconductor industry is in a high-stakes race, with artificial intelligence (AI) igniting a global battle for technological supremacy. For a lot of investors, picking the ultimate winner among the industry's array of titans can feel like a speculative bet.

Raytheon's $646.5M radar contract win reinforces RTX's key role in next-gen naval defense technology.

Circle Internet Group Inc (NYSE: CRCL), the issuer of the USDC stablecoin, has rapidly emerged as one of the market's most watched stories following its IPO. Currently trading around $115 — a significant increase from its IPO reference price of $31 — the company has attracted substantial institutional support and increasing public interest from investors.

After months of false starts and frustrating sideways action, Qualcomm Inc. NASDAQ: QCOM gave investors something to get excited about on Monday. Shares of the tech giant jumped 4% in one of their best single-day performances in recent weeks, dramatically outperforming the broader S&P 500, which gained less than 1% on the day.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In UroGen To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in UroGen between July 27, 2023 and May 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 10, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against UroGen Pharma Ltd.

Investors need to pay close attention to AKR stock based on the movements in the options market lately.

CF shares jump 21% in 3 months as nitrogen demand surges, prices rise and buybacks boost shareholder returns.

Get a deeper insight into the potential performance of RH (RH) for the quarter ended April 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Crown (CCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Explore Ciena's (CIEN) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Catalyst (CPRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.